Navigation Links
US Oncology Research Affiliated Physicians to Present at 2011 ASCO Annual Meeting
Date:5/26/2011

eam


  • Understanding Male Breast Cancer in the Community Setting.Debra Patt, MD, Janet Espirito, PharmD, Brian Turnwald, J. Russell Hoverman, MD, Marcus Neubauer, MD, Thomas Cartwright, MD, Barry Brooks, MD, Leslie Busby, MD, Mark Sitarik, MD, Michael Kolodziej, MD, Aimee Ginsburg, PharmD, Sheetal Sheth, PharmD, Jody Garey, PharmD, Matthew Clayton, Greg Nelson, Roger Anderson, DrPH, Roy Beveridge, MD; on behalf of the US Oncology Pathways Task Force and Clinical Content Development Team


  • Utilization and relative value of breast cancer adjuvant chemotherapy regimens in the community.Avani Joshi, PhD, Healthcare Informatics, US OncologyDavid Fryefield, MD, Willamette Valley Cancer Institute and Research CenterMichael Forsyth, RPh, MBA, Rocky Mountain Cancer CentersWilliam Lopez, Healthcare Informatics, US Oncology


  • Demographic and treatment characteristics for advanced basal cell carcinoma (aBCC) in an oncology outpatient setting.Thomas Cartwright, MD, Ocala Oncology CenterMichael Forsyth, RPh, MBA, Rocky Mountain Cancer CentersHeather Hartnett, PhD, Hsingwen Chung, MS, Melissa Halm, MPH, Healthcare Informatics, US Oncology


  • mCRC - Survival Outcomes with the use of Bevacizumab beyond progression in metastatic colorectal cancer patients.Clara Chen, MS, Healthcare Informatics, US OncologyDebra Patt, MD, MPH, Texas OncologyMichael Forsyth, RPh, MBA, Rocky Mountain Cancer CentersDenise Kazzaz, Jeff Shankleton, Ramachandran Ganesh, Healthcare Informatics, US Oncology


  • Evaluation of relation between Oncotype DX recurrence score and adjuvant chemotherapy administration.Kavita Sail, MS, PhD, Healthcare Informatics, US OncologyDebra Patt, MD, MPH, Texas OncologyMichael Forsyth, RPh, MBA, Rocky Mountain Cancer CentersMelissa Halm, MPH, William Lopez, Healthcare Informatics, US Oncology



  • SOURCE US Oncology, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
    3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
    4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
    5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
    6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
    7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
    8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
    9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
    10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
    11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
    (Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
    (Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
    Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
    ... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
    ... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
    Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
    (Date:6/29/2015)... ... June 29, 2015 , ... Scientists from the Icahn School ... complete genomes by combining high-throughput DNA sequencing with genome mapping. The methodology enabled ... with human disease, but previously difficult to detect. The study was published today ...
    (Date:6/29/2015)... Fernando Valley, CA (PRWEB) , ... June 29, 2015 , ... ... non-invasive treatments designed to lift and tighten sagging skin. Ulthera is a special treatment ... surgery. Instead, it uses ultrasound technology to gently stimulate collagen production. Ulthera is highly ...
    (Date:6/29/2015)... ... June 29, 2015 , ... The ... Chemical Technology of The Hong Kong Polytechnic University (PolyU) has developed a new ... of edible oils has been a long-term issue in food safety, and becomes ...
    (Date:6/29/2015)... ... June 29, 2015 , ... ... company serving the Twin Cities area, provides money-saving tactics during a season of ... Twin Cities’ residents, addressing water conservation and other economical practices. , According to ...
    (Date:6/29/2015)... ... , ... BaliniSports has been announced as an official sponsor and apparel provider ... This year’s contestants will be wearing pieces from the BaliniSports collection during practice sessions ... on to represent the state in the Miss Teen USA competition. , “BaliniSports ...
    Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 2Health News:Save Energy: MSP Plumbing, Heating & Air Endorses Efficiency 3Health News:BaliniSports Announced as Sponsor of the Miss Teen Nevada 2016 Competition 2
    ... study, published online in the Journal of Allergy ... therapies against childhood eczema in attempt to reduce the ... conducted by the University of Melbourne, Monash University and ... 8500 people who are part of the Tasmanian Longitudinal ...
    ... Dental researchers at the University of Washington have reported ... treated with the topical syrup xylitol, a naturally occurring ... General Session of the International Association for Dental Research. ... of the Marshall Islands, children 6 to 15 months ...
    ... mechanism present early in life predisposes people to worry, ... The brains of people who suffer from anxiety and ... show signs of being anxious even in situations considered ... Wisconsin School of Medicine and Public Health. , ...
    ... or tooth decay, continues to be the most prevalent ... and socio-economic consequences. It leads to the loss of ... necrosis of the subjacent dental pulp. In the U.S. ... with failure rates of up to 60%. Hence, there ...
    ... July 4 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: ... of medical devices worldwide, today announced it has ... audited financial statements for,the fiscal year ended December ... (the "SEC") in accordance with United States,requirements. Mindray,s ...
    ... July 3 The July 5 issue of ... of Istanbul,on Organ Trafficking and Transplant Tourism, an ... May 2, 2008, at an,International Summit of more ... scholars from 78 countries and 20,international organizations. A ...
    Cached Medicine News:Health News:Anxiety, Shyness May Be Long-Lasting Traits 2Health News:Novel hydrogel systems for dentin regeneration 2Health News:Mindray Announces 20-F Filing 2Health News:Commentary in The Lancet on the Declaration of Istanbul Sees Organ Transplantation Worldwide Threatened by Organ Trafficking and Transplant Tourism and Commercialism 2
    Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
    Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
    Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
    Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
    Medicine Products: